Herd immunity or suppression strategy to combat COVID-19

被引:23
|
作者
Jung, F. [1 ]
Krieger, V. [2 ]
Hufert, F. T. [3 ,4 ]
Kuepper, J. -H. [1 ,4 ]
机构
[1] Brandenburg Tech Univ Cottbus, Inst Biotechnol, Mol Cell Biol, Senftenberg, Germany
[2] TMM AG Boblingen, Dept Head Lab Planning & Norming Informat Managem, Boblingen, Germany
[3] Brandenburg Med Sch, Inst Microbiol & Virol, Senftenberg, Germany
[4] Brandenburg Med Sch Theodor Fontane & Univ Potsda, Joint Fac Brandenburg Univ Technol Cottbus Senfte, Fac Hlth Sci, Potsdam, Germany
关键词
COVID-19; strategy; Sweden; Taiwan; Germany;
D O I
10.3233/CH-209006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Some months ago, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, and spread rapidly around the world. Some states, such as the Netherlands, Germany, Great Britain, Sweden and the USA initially focused on keeping the restrictions for economy and society as low as possible. The responsible authorities were of the opinion - and still are e.g. in Sweden - that it is sufficient enough to protect particularly vulnerable persons such as the elderly or people with pre-existing conditions. The idea behind this is that as soon as 60 to 70 percent of the population is infected with a pathogen, a so-called "herd immunity" has developed. However, the increasing numbers of deaths and modelling studies showed the expected overload of the hospitals. Therefore, most countries decided for a temporary lockdown with the exception of Sweden. Based on the number of the total population, three times more people died from COVID-19 in Sweden (2679 deaths per 10 million inhabitants) compared to Germany (6848 deaths per 80 million inhabitants). The comparison Sweden versus Taiwan is even worse because 1072 times more people died in Sweden based on the number of the population (6 deaths per 24 million inhabitants). In the face of the lack of an antiviral treatment and the lack of a protective vaccine one must state Taiwan has made the best out of the pandemic situation whereas Sweden failed completely.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [41] Radicalizing moral conservatism in herd immunity during COVID-19
    Kahambing, Jan Gresil
    JOURNAL OF PUBLIC HEALTH, 2022, 44 (04) : E606 - E607
  • [42] COVID-19: Herd immunity and convalescent plasma transfer therapy
    Syal, Kirtimaan
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1380 - 1382
  • [43] COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
    Khalife, Jade
    VanGennep, Derrick
    EPIDEMIOLOGY AND HEALTH, 2021, 43
  • [44] Herd immunity in COVID-19: Needs de-emphasizing
    Raina, Sunil Kumar
    Kumar, Raman
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (05) : 1595 - 1597
  • [45] Can India develop herd immunity against COVID-19?
    A. Gowrisankar
    Lamberto Rondoni
    Santo Banerjee
    The European Physical Journal Plus, 135
  • [46] COVID-19: Is herd immunity the only option for fragile Yemen?
    Noushad, Mohammed
    Al-Saqqaf, Inas Shakeeb
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 106 : 79 - 82
  • [47] The Concept of Classical Herd Immunity May Not Apply to COVID-19
    Morens, David M.
    Folkers, Gregory K.
    Fauci, Anthony S.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (02): : 195 - 198
  • [48] Herd immunity: could it bring the COVID-19 pandemic to an end?
    Pennington, Thomas Hugh
    FUTURE MICROBIOLOGY, 2021, 16 (06) : 371 - 374
  • [49] Caveats on COVID-19 herd immunity threshold: the Spain case
    David García-García
    Enrique Morales
    Eva S. Fonfría
    Isabel Vigo
    Cesar Bordehore
    Scientific Reports, 12
  • [50] Can COVID-19 herd immunity be achieved at a city level?
    Arbel, Yuval
    Arbel, Yifat
    Kerner, Amichai
    Kerner, Miryam
    PLOS ONE, 2024, 19 (05):